Faeth Therapeutics, Inc. (FTH) Operating cash flow 2020–2025
Faeth Therapeutics, Inc. (FTH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$20.5MFY2025 · since FY2020: -$17.7M → -$20.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.5M | +17.1% |
| FY2024 | -$24.7M | +23.0% |
| FY2023 | -$32.0M | +17.9% |
| FY2022 | -$39.0M | -29.0% |
| FY2021 | -$30.3M | -70.9% |
| FY2020 | -$17.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice